GlassScriptPhysician profile
Timothy R Thaller
NPI 1407849706
$998.31
in general payments reported to CMS, 2019-2025
15 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $46.85 · 2021: $337 · 2022: $101 · 2023: $116 · 2024: $168 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $506.05 | 2019-2023 | Myrbetriq |
| Tolmar, INC. | $79.21 | 2023-2024 | |
| Boston Scientific Corporation | $70.96 | 2024 | Ams 700 |
| Sumitomo Pharma America, INC. | $56.01 | 2023-2025 | Gemtesa |
| Mindray Ds USA, INC. | $48.42 | 2024 | Te7 Max, Te X |
| Myovant Sciences INC. | $43.47 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.75 | 2025 | |
| Blue Earth Diagnostics | $29.08 | 2021 | |
| Pfizer INC. | $28.94 | 2019-2022 | |
| Endo USA, INC. | $26.55 | 2025 | Xiaflex |
| Accord Healthcare, INC. | $19.87 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $18.36 | 2025 | Bard Urinary Drainage Bag |
| Merck Sharp & Dohme LLC | $17.46 | 2024 | Keytruda |
| Urovant Sciences INC | $11.69 | 2021 | |
| Travere Therapeutics, INC. | $2.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Thaller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.